Organisation - Management and Board

Management

 

CEO Ulrika Hammarström Lüllmaa - holds a Master of Science in molecular biology as well as a postgraduate qualification in “Clinical Drug Development” from Uppsala University. Ulrika has worked in the CRO business since 2001 and has experience from positions such as CRA Manager, Clinical Project Leader and Country Manager. Ulrika Hammarstrom Lüllmaa holds the position of CEO at SCRO

 

Biostatistics and Data Management Manager Catarina Jansson Blixt - Responsible for the biostatistics and data management activities in all in-house projects. Acting study biostatistician and as such involved in for example the development of study protocols, SAPs (Statistical Analysis Plans) and clinical study reports.

Catarina has 25 years of experience in Clinical trials. She started her career at Medical Products Agency where her main duties consisted of reviewing phase II-IV study protocols and to act as a discussing partner for the industry and Investigators in statistical issues. In 2001 she was hired to build the new Nordic Biometrics department at Pfizer AB and during her seven years she successfully held responsibility for the biostatistics activities in all clinical trials within the Nordic countries.

 

Clinical Operation Manager, Marie Wiklander - responsible for the clinical trial management services and resourses.

Marie has more than 25 years of experience in Pharmaceutical Development in various companies/authority and positions of which 14 years of experience in clinical trials in different therapeutic areas. She has been in various positions at both R&D sites (Pharmacia and Q-Med/Galderma) and CRO (Quintiles). These positions included e.g. global study program management, protocol development, coordination of study teams, negotiation/cooperation with CRO, monitoring and handling of study documentation, applications.

The past 13 years Marie has been in management positions, Clinical Operation Manager at Q-Med, Manager at Quality Assurance Department at Q-Med and her latest position was Head of Section at Regulatory Administration (New application) at the Medical Products Agency.

Board

Ulf Boberg,  Chairman of the Board

Ulf holds a Master's degree in Pharmacy, a Ph.D. in Physiology, and a Master’s degree in Business Development and Economics (MBAexec), all at Uppsala University.

Ulf was a medical director at Gambro AB in the late 80's and then CEO of PMC Clinical Research AB, who commissioned clinical trials for international pharmaceutical companies. He has been active as CEO and business developer in many companies in pharmacological and medical development since 1993. Ulf was recruited in 1998 as Deputy CEO and Development Manager of Astra Pain Control, and went on to other assignments following the merger with Zeneca in 1999.

 

Since 2000, Ulf has been active as CEO of a number of small pharmaceutical and biotechnology companies: Global Genomics AB, Affibody AB, and Creative Antibiotics AB. Ulf worked as a consultant with 'Tissue Re-engineering' for NovaHep AB 2013–2014. Ulf was CEO of Miris Holding AB from 2014 to 2016. He has been Chairman of the Board of Alfta Rehab Center, Trial Form Support AB, iNovacia AB (today Kancera AB), and SpectraCure AB.

 

 

Ingrid Steringer - former director at Pfizer, is now joining the board of SCRO. After thirteen years at Pfizer and twenty years at Pharmacia, both in Stockholm and Uppsala, and with experience of clinical trials in Sweden as well as the other Nordic countries and the Baltic countries.

 

 

Jens Mattsson - is a trained economist with a background in banking and insurance. He has worked at SEB for 10 years and held positions such as asset manager as well as various other management positions. Currently Jens acts as economic adviser to the former owners of Radi Medical. He sits on a number of boards one of which is AprioMed.

 

 

Thomas Lüllmaa - partner and CEO of Riksmäklaren, a family business in Uppsala with a 35-year history. In addition, Thomas is a partner in several real estate companies and a member of several boards in the property management and clothing industries.

 

 

Ulrika Hammarström Lüllmaa - see above.